×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Softgel Capsule Market

ID: MRFR/Pharma/47932-HCR
200 Pages
Rahul Gotadki
October 2025

China Softgel Capsule Market Research Report By Type (Gelatin Type, Non-Animal Type) and By Application (Vitamins, Supplement, Nutrition)-Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Softgel Capsule Market Infographic
Purchase Options

China Softgel Capsule Market Summary

As per MRFR analysis, the softgel capsule market size was estimated at $415.72 Million in 2024. The softgel capsule market is projected to grow from 438.83 $ Million in 2025 to 753.54 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.56% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The China softgel capsule market is experiencing robust growth driven by evolving consumer preferences and technological advancements.

  • The largest segment in the China softgel capsule market is nutraceuticals, reflecting a rising demand for health-oriented products.
  • The fastest-growing segment is plant-based formulations, indicating a shift towards more sustainable and natural options.
  • Technological advancements in production are enhancing the efficiency and quality of softgel capsules, contributing to market expansion.
  • Key market drivers include increasing health awareness and the aging population, which are significantly influencing consumer choices.

Market Size & Forecast

2024 Market Size 415.72 (USD Million)
2035 Market Size 753.54 (USD Million)
CAGR (2025 - 2035) 5.56%

Major Players

Catalent (US), Amway (US), BASF (DE), Lonza (CH), FMC Corporation (US), Aenova Group (DE), Soft Gel Technologies (US), Natural Alternatives International (US)

China Softgel Capsule Market Trends

The softgel capsule market is experiencing notable growth, driven by increasing consumer demand for dietary supplements and pharmaceuticals. This growth is largely attributed to the convenience and ease of consumption that softgel capsules offer. They are often preferred over traditional tablets due to their ability to mask unpleasant tastes and enhance bioavailability. Additionally, the rising awareness of health and wellness among consumers is propelling the market forward, as more individuals seek out supplements to support their overall well-being. Furthermore, advancements in manufacturing technologies are enabling the production of softgel capsules with improved formulations, catering to diverse consumer needs. Moreover, the softgel capsule market is witnessing a shift towards plant-based and natural ingredients, reflecting a broader trend towards sustainability and health consciousness. As consumers become more discerning about the products they consume, manufacturers are responding by developing softgel capsules that align with these values. This trend is likely to continue, as the market adapts to the evolving preferences of health-conscious consumers. The regulatory landscape in China is also evolving, with stricter guidelines aimed at ensuring product safety and efficacy, which may further influence market dynamics in the coming years.

Rising Demand for Nutraceuticals

The softgel capsule market is seeing a surge in demand for nutraceutical products. Consumers are increasingly turning to dietary supplements for health benefits, which is driving manufacturers to innovate and expand their offerings. This trend reflects a growing awareness of preventive healthcare and the role of supplements in maintaining wellness.

Shift Towards Plant-Based Formulations

There is a noticeable shift towards plant-based formulations within the softgel capsule market. As consumers become more health-conscious and environmentally aware, manufacturers are responding by developing softgel capsules that utilize natural ingredients. This trend aligns with the broader movement towards sustainability and clean-label products.

Technological Advancements in Production

Technological advancements are playing a crucial role in the evolution of the softgel capsule market. Innovations in manufacturing processes are enabling the production of capsules with enhanced bioavailability and stability. These advancements not only improve product quality but also cater to the diverse needs of consumers seeking effective supplement solutions.

China Softgel Capsule Market Drivers

Aging Population

China's demographic shift towards an aging population is significantly impacting the softgel capsule market. With an increasing number of elderly individuals, there is a growing need for health supplements that cater to age-related health issues. Softgel capsules, which are often easier to swallow and digest, are becoming a preferred choice for older consumers. This demographic trend suggests that the market could see a substantial increase in demand, potentially reaching $2 billion by 2027. The softgel capsule market is likely to adapt by developing formulations specifically targeting the nutritional needs of seniors, thereby expanding its consumer base.

E-commerce Growth

The rapid expansion of e-commerce in China is reshaping the softgel capsule market landscape. Online platforms provide consumers with convenient access to a wide range of health supplements, including softgel capsules. This shift towards online shopping is particularly appealing to younger demographics who prefer the convenience of purchasing products from home. In 2025, e-commerce sales in the health supplement sector are expected to account for over 30% of total sales, indicating a significant shift in consumer purchasing behavior. The softgel capsule market must leverage this trend by enhancing online visibility and optimizing distribution channels to meet the evolving demands of consumers.

Rising Disposable Income

The increase in disposable income among Chinese consumers is a key driver for the softgel capsule market. As individuals have more financial resources, they are more inclined to invest in health and wellness products, including dietary supplements. This trend is particularly evident in urban areas, where consumers are increasingly prioritizing health-related expenditures. The softgel capsule market is likely to see a surge in demand, with projections indicating a market value of $1.8 billion by 2026. This rise in disposable income not only expands the consumer base but also encourages manufacturers to diversify their product offerings to cater to varying consumer preferences.

Increasing Health Awareness

The softgel capsule market in China is experiencing growth driven by a notable increase in health awareness among consumers. As individuals become more conscious of their health and wellness, there is a rising demand for dietary supplements and nutraceuticals. This trend is reflected in the market, where the demand for softgel capsules, known for their ease of consumption and effective delivery of nutrients, is on the rise. In 2025, the market is projected to reach approximately $1.5 billion, indicating a compound annual growth rate (CAGR) of around 8%. This heightened focus on preventive healthcare is likely to propel the softgel capsule market further, as consumers seek convenient and effective ways to enhance their health.

Regulatory Support for Nutraceuticals

The Chinese government is increasingly supportive of the nutraceutical sector, which positively influences the softgel capsule market. Recent regulatory frameworks aim to promote the development and safety of dietary supplements, encouraging manufacturers to innovate and expand their product offerings. This supportive environment is likely to foster growth within the softgel capsule market, as companies can more confidently invest in research and development. By 2026, the market is projected to grow by 10%, driven by new product launches and improved safety standards. The softgel capsule market stands to benefit from these regulatory changes, enhancing consumer trust and market penetration.

Market Segment Insights

China Softgel Capsule Market Segment Insights

China Softgel Capsule Market Segment Insights

Softgel Capsule Market Type Insights

Softgel Capsule Market Type Insights

The China Softgel Capsule Market is experiencing notable advancements, particularly within the Type segment, which encompasses distinct categories such as Gelatin Type and Non-Animal Type. The growing consumer preference toward health and wellness products is herding significant investments into softgel capsules, which are often preferred for their user-friendly application, rapid disintegration, and effective delivery of nutrients. Gelatin Type softgels, which are derived from animal sources, hold a long-established dominance in the market, attributed to their proven efficacy and widespread acceptance among consumers.

This segment is often favored for the encapsulation of dietary supplements and pharmaceuticals, where stability and content protection are crucial. Conversely, the Non-Animal Type segment reflects the evolving consumer demand for plant-based options, catering especially to vegetarian and vegan populations. This category is gaining traction amid an increasing focus on ethical consumption and animal welfare, signifying a paradigm shift in dietary supplement production in China. These types of softgels are often crafted from hydroxypropyl methylcellulose or other plant-derived materials, making them suitable alternatives without compromising efficacy.

The rapid growth in health awareness among the Chinese population, along with rising disposable incomes, is driving significant opportunities for both Gelatin and Non-Animal Type products in the market. Moreover, the segmentation within the China Softgel Capsule Market data reveals how these types address distinct consumer needs, enhancing market growth through diversified offerings. Companies are continuously innovating to meet consumer preferences, with R&D efforts heavily geared towards improving the formulation and manufacturing processes for both gelatin and non-animal softgels. Regulatory support for health-related products, along with favorable market trends, further promotes the adoption of softgel capsules across various consumer demographics.

With the evolving landscape in dietary habits and an increasing emphasis on wellness, the Type segment of the China Softgel Capsule Market is set to play a pivotal role in meeting future demands.

Softgel Capsule Market Application Insights

Softgel Capsule Market Application Insights

The China Softgel Capsule Market epitomizes a vibrant and expanding industry, particularly within the Application segment, which includes Vitamins, Supplements, and Nutrition. With a recognized increase in health awareness among consumers, the demand for softgel capsules has escalated, fueled by the fast-paced lifestyle and the need for convenient dosage forms.

The Vitamins segment is significant as it benefits from a growing trend towards preventive healthcare, leading to higher consumption among the aging population and fitness enthusiasts alike.Similarly, the Supplement segment is thriving due to a rising interest in holistic health and wellness products, addressing diverse needs such as immunity enhancement and overall vitality. Nutrition, encompassing essential nutrients, plays a critical role in supporting dietary gaps and maintaining health. This segment is crucial for the population's well-being, as nutrition-focused products have gained traction in response to increased awareness regarding dietary deficiencies.

As the China Softgel Capsule Market continues to grow, these segments will be integral in shaping the industry's trajectory, further driven by favorable government initiatives promoting health and dietary supplements.

Get more detailed insights about China Softgel Capsule Market

Key Players and Competitive Insights

The softgel capsule market exhibits a dynamic competitive landscape, characterized by a blend of innovation, strategic partnerships, and regional expansion. Key players such as Catalent (US), Lonza (CH), and BASF (DE) are at the forefront, leveraging their extensive expertise in pharmaceutical and nutraceutical formulations. Catalent (US) has positioned itself as a leader through its focus on advanced delivery technologies and robust manufacturing capabilities, while Lonza (CH) emphasizes its commitment to sustainability and high-quality production processes. BASF (DE), on the other hand, is enhancing its market presence by integrating digital solutions into its operations, thereby streamlining production and improving customer engagement. Collectively, these strategies not only enhance their competitive edge but also contribute to a rapidly evolving market environment.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. This approach appears to be particularly effective in a moderately fragmented market, where the collective influence of key players shapes pricing strategies and product availability. The emphasis on supply chain optimization is evident as firms seek to mitigate risks and enhance operational efficiency, which is crucial in maintaining competitiveness in this sector.

In October 2025, Catalent (US) announced a strategic partnership with a leading Chinese nutraceutical firm to co-develop a new line of softgel products aimed at the growing health-conscious consumer segment. This collaboration is significant as it not only expands Catalent's footprint in the Chinese market but also aligns with the increasing demand for innovative health solutions. The partnership is expected to leverage both companies' strengths, potentially leading to enhanced product offerings and market penetration.

In September 2025, Lonza (CH) unveiled its new state-of-the-art manufacturing facility in China, designed to produce softgel capsules with a focus on sustainability. This facility is anticipated to utilize advanced technologies that minimize waste and energy consumption, reflecting Lonza's commitment to environmentally friendly practices. The establishment of this facility is likely to bolster Lonza's production capacity and reinforce its position as a leader in sustainable manufacturing within the softgel segment.

In August 2025, BASF (DE) launched a digital platform aimed at enhancing customer interaction and streamlining the ordering process for softgel products. This initiative is indicative of the growing trend towards digitalization in the industry, as it allows for greater efficiency and responsiveness to customer needs. By integrating technology into its operations, BASF is not only improving its service delivery but also setting a benchmark for competitors in the market.

As of November 2025, the competitive trends in the softgel capsule market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and enhancing market reach. Looking ahead, it is likely that competitive differentiation will evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine the competitive landscape, compelling companies to adapt and innovate continuously.

Key Companies in the China Softgel Capsule Market market include

Industry Developments

The China Softgel Capsule Market has seen notable developments recently, with companies like Fujian Jintai Pharmaceutical and Baiyunshan Pharmaceutical actively expanding their production capabilities amid increasing demand. In September 2023, Dongying Yimeike Pharmaceutical announced its investment in new technologies to enhance the encapsulation process, focusing on quality and efficiency. Meanwhile, MediGel and Harbin Pharmaceutical are collaborating to innovate formulations tailored to consumer health trends, indicating a shift toward personalized medicine. In terms of mergers and acquisitions, Ashareda and Chengdu Luyin Pharmaceutical explored strategic alliances to leverage market reach, with announcements in August 2023.

Additionally, Boehringer Ingelheim has shown interest in joint ventures to enhance its footprint in China's growing market. The current valuation of the softgel capsule sector is on an upswing, driven by an increase in health consciousness among consumers and the promotion of dietary supplements. Over the last two years, significant happenings, such as Hainan Haiyao's expansion of its product line in June 2022, have positively impacted market dynamics, with heightened competition among industry players, including Zhejiang Guangxia Pharmaceutical and Cangzhou ZhiHua Pharmaceutical.

 

Future Outlook

China Softgel Capsule Market Future Outlook

The Softgel Capsule Market is projected to grow at a 5.56% CAGR from 2024 to 2035, driven by increasing health awareness and demand for dietary supplements.

New opportunities lie in:

  • Expansion of plant-based softgel formulations
  • Development of customized softgel delivery systems
  • Investment in advanced manufacturing technologies for efficiency

By 2035, the market is expected to achieve substantial growth and innovation.

Market Segmentation

China Softgel Capsule Market Application Outlook

  • Nutraceuticals
  • Pharmaceuticals
  • Cosmetics
  • Vitamins
  • Dietary Supplements

China Softgel Capsule Market Formulation Outlook

  • Single Phase
  • Multi-Phase
  • Emulsified
  • Suspended
  • Gelled

China Softgel Capsule Market Ingredients Outlook

  • Gelatin
  • Fish Gelatin
  • Vegetable Gelatin
  • Active Ingredients
  • Colorants

China Softgel Capsule Market Distribution Channel Outlook

  • Online Retail
  • Pharmacies
  • Health Stores
  • Supermarkets
  • Direct Sales

Report Scope

MARKET SIZE 2024 415.72(USD Million)
MARKET SIZE 2025 438.83(USD Million)
MARKET SIZE 2035 753.54(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.56% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Million
Key Companies Profiled Catalent (US), Amway (US), BASF (DE), Lonza (CH), FMC Corporation (US), Aenova Group (DE), Soft Gel Technologies (US), Natural Alternatives International (US)
Segments Covered Application, Ingredients, Formulation, Distribution Channel
Key Market Opportunities Growing demand for plant-based softgel capsules driven by consumer health trends and sustainability concerns.
Key Market Dynamics Rising demand for dietary supplements drives innovation and competition in the softgel capsule market.
Countries Covered China

Leave a Comment

FAQs

What is the expected market size of the China Softgel Capsule Market in 2024?

The China Softgel Capsule Market is expected to be valued at 720.0 USD Million in 2024.

What is the projected market size for the China Softgel Capsule Market by 2035?

By 2035, the China Softgel Capsule Market is projected to reach a valuation of 1490.0 USD Million.

What is the expected CAGR for the China Softgel Capsule Market from 2025 to 2035?

The expected CAGR for the China Softgel Capsule Market from 2025 to 2035 is 6.835 percent.

Which segment of the China Softgel Capsule Market has the largest share in 2024?

In 2024, the Gelatin Type segment is expected to have the largest share valued at 400.0 USD Million.

What is the market size for the Non-Animal Type softgel capsules in 2024?

The Non-Animal Type softgel capsules are valued at 320.0 USD Million in 2024.

Who are the major players in the China Softgel Capsule Market?

Major players in the China Softgel Capsule Market include Fujian Jintai Pharmaceutical, Baiyunshan Pharmaceutical, and Boehringer Ingelheim among others.

What is the expected market value for Gelatin Type softgel capsules in 2035?

The Gelatin Type softgel capsules are expected to be valued at 840.0 USD Million by 2035.

What is the expected market value for Non-Animal Type softgel capsules by 2035?

By 2035, the Non-Animal Type softgel capsules are projected to reach 650.0 USD Million.

What challenges are expected to affect the growth of the China Softgel Capsule Market?

Challenges in the China Softgel Capsule Market may include regulatory hurdles and competition from alternative dosage forms.

What growth drivers are influencing the China Softgel Capsule Market?

Increasing demand for dietary supplements and pharmaceutical applications are key growth drivers in the China Softgel Capsule Market.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions